OpenVSafe by OpenVAERS
Search V-safe

FB6-23300-84062

3 vaccinations 8 coded responses 15 check-ins 7 free-text entries 6 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
185 / PA
Registered
2021-02-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Dose 1 — Moderna
  2. 2021-02-04
    Dose 2 — Moderna
  3. 2021-02-07
    Registered in v-safe
  4. 2021-02-11
    Survey response — day 7, dose 2
    MedDRA: Tachycardia — Feeling: Good · Site: Itching
    Free text: Persistent tachycardia with exertion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-02-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-03-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-03-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-05-09
    Survey response — 3 months, dose 2
    MedDRA: Cellulitis, Erythema, Hospitalisation, Skin warm, Tenderness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Cellulitis to my right lower leg requiring hospitalization for IV antibiotics. After my 2nd vaccine, same area of my leg became red, hot, tender to touch, and swollen but faded after 24 hours. Weird coincidence that I woke w cellulitis in same spot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-09
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-08-05
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-01-19
  14. 2022-02-04
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Exercise tolerance decreased, Fatigue, Vaccination site pain — Feeling: Good · Be unable to do your normal daily activities
    Free text: When I got actual Covid infection and was symptomatic, the site of vaccination was very sore. It is still tender when touched even though it's been a few weeks since infection. I am more tired and more activity intolerant after infection than before.
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-03-28
    Dose 3 — Moderna
  16. 2022-04-27
    Survey response — day 28, dose 3
    MedDRA: Brain fog, Headache, Mental status changes, Ophthalmic migraine, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Headaches, ocular migraines, visual disturbances, brain fog, mental status changes
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-04-27
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  18. 2022-05-02
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  19. 2022-05-09
    Survey response — day 42, dose 3
    MedDRA: Headache, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Continued headaches and visual disturbances.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-05-09
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  21. 2022-05-10
  22. 2022-06-29
    Survey response — 3 months, dose 3
    MedDRA: Dyspnoea, Exercise tolerance decreased, Migraine, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Persistent activity intolerance Shortness of breath Visual disturbances Migraines
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-06-29
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  24. 2022-06-30
  25. 2022-09-28
    Survey response — 6 months, dose 3
    MedDRA: Cardiomyopathy, Diabetes mellitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cardiomyopathy Diabetes
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-09-28
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  27. 2022-09-29
  28. 2022-09-29
  29. 2022-09-29
  30. 2022-09-29
  31. 2023-03-28
    Survey response — 12 months, dose 3
    MedDRA: Dyspnoea, Palpitations — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  32. 2023-03-28
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2023-03-29
  34. 2023-03-29
  35. 2023-03-29
  36. 2023-03-29
  37. 2023-03-29
  38. 2023-04-27
  39. 2023-04-27
  40. 2023-04-27
  41. 2023-04-27
  42. 2023-04-27
  43. 2023-04-28
  44. 2023-04-28
  45. 2023-04-28
  46. 2023-04-28
  47. 2023-04-28

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Moderna
22021-02-04Moderna
32022-03-28Moderna No

Call center

6 call center cases

1 successful · 5 unsuccessful

VAERS report filed, before or during a call: 1

3 waits over 3 months for a first call

See the call center timeline

Free text

Release 4 — day 7, dose 2

2021-02-11

Systemic reaction (other): Persistent tachycardia with exertion

Release 8 — 3 months, dose 2

2021-05-09

Symptoms: Cellulitis to my right lower leg requiring hospitalization for IV antibiotics. After my 2nd vaccine, same area of my leg became red, hot, tender to touch, and swollen but faded after 24 hours. Weird coincidence that I woke w cellulitis in same spot. cut off by CDC

Release 11 — 12 months, dose 2

2022-02-04

Symptoms: When I got actual Covid infection and was symptomatic, the site of vaccination was very sore. It is still tender when touched even though it's been a few weeks since infection. I am more tired and more activity intolerant after infection than before. cut off by CDC

Release 11 — day 28, dose 3

2022-04-27

Symptoms: Headaches, ocular migraines, visual disturbances, brain fog, mental status changes

Release 11 — day 42, dose 3

2022-05-09

Symptoms: Continued headaches and visual disturbances.

Release 12 — 3 months, dose 3

2022-06-29

Symptoms: Persistent activity intolerance Shortness of breath Visual disturbances Migraines

Release 12 — 6 months, dose 3

2022-09-28

Symptoms: Cardiomyopathy Diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBrain fog · · ✓
SDCardiomyopathy · · ✓
SDCellulitis ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDiabetes mellitus · · ✓
SDDyspnoea · · ✓
SDErythema ✓ ✓ ✓
SDExercise tolerance decreased · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHospitalisation ✓ ✓ ✓
SDMental status changes · · ✓
SDMigraine · · ✓
SDOphthalmic migraine · · ✓
SDPalpitations · · ✓
SDSkin warm ✓ ✓ ✓
SDTenderness ✓ ✓ ✓
SDVaccination site pain · · ✓
SDVisual impairment · · ✓
SROTachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release